Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B‐Cell Lymphoma Who Are Poor Candidates for R‐CHOP Chemotherapy

LESSONS LEARNED. The combination of ofatumumab and bendamustine in elderly patients with diffuse large B‐cell lymphoma demonstrated modest efficacy compared with standard of care. The poor response may have been due to patient age and the high rate of treatment discontinuation. BACKGROUND. This phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Flinn, Ian W., Erter, Jack, Daniel, Davey B., Mace, Joseph R., Berdeja, Jesus G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693706/
https://www.ncbi.nlm.nih.gov/pubmed/31073022
http://dx.doi.org/10.1634/theoncologist.2019-0286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693706/
https://www.ncbi.nlm.nih.gov/pubmed/31073022
http://dx.doi.org/10.1634/theoncologist.2019-0286

Ejemplares similares